Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home News room Press releases
Press Releases

2009

02/07/2009
ABLYNX PROMOTED TO THE BELGIAN MID-CAP INDEX
NL

29/06/2009
ABLYNX ANNOUNCES A NOVEL PRECLINICAL DEVELOPMENT CANDIDATE TARGETING IL6R
NL

26/06/2009
ABLYNX WINS EUROPEAN MEDISCIENCE AWARD FOR BEST TECHNOLOGY
NL

25/05/2009
Ablynx appoints Medical Director and Business Development Director
NL

07/05/2009
ABLYNX ANNOUNCES THAT ITS vWF NANOBODY® PROGRAMME HAS BEEN GRANTED ORPHAN DRUG DESIGNATION AND PROVIDES A BUSINESS UPDATE FOR THE FIRST QUARTER 2009
NL

30/03/2009
ABLYNX REPORTS DETAILED POSITIVE PHASE Ib RESULTS FOR ITS ANTI-THROMBOTIC NANOBODY® ALX-0081
NL

24/02/2009
ABLYNX ANNOUNCES 2008 FULL YEAR RESULTS
NL

18/02/2009
ABLYNX WILL ANNOUNCE FULL YEAR RESULTS FOR 2008 WITH WEBCAST
NL

05/02/2009
ABLYNX ANNOUNCES SECOND EXTENSION OF ITS NANOBODY® DRUG DISCOVERY AND DEVELOPMENT ALLIANCE
NL

03/02/2009
ABLYNX RECEIVES €3 MILLION IN MILESTONE PAYMENTS AS PART OF ITS STRATEGIC ALLIANCE WITH BOEHRINGER INGELHEIM
NL

20/01/2009
ABLYNX EXPANDS ITS MUSCULOSKELETAL PORTFOLIO BY TAKING P&G PHARMACEUTICALS' PROGRAMME IN-HOUSE
NL

14/01/2009
ABLYNX ANNOUNCES TECHNICAL ADVANCES IN ITS NANOBODY® PLATFORM TECHNOLOGY: ENHANCED BENEFITS FROM PULMONARY DELIVERY AND HALF-LIFE EXTENSION
NL

12/01/2009
ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE 27TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
NL

08/01/2009
ABLYNX STRENGTHENS MANAGEMENT TEAM WITH THE APPOINTMENT OF DR DEBBIE LAW AS CHIEF SCIENTIFIC OFFICER
NL

















 

Press releases

  • 2009

News archive

Email alerts

If you would like to receive updates on the company news, please
click here